What’s Going On With Amazon Stock Today?
Amazon.com, Inc. (NASDAQ: AMZN) shares are roughly flat at $108.29 during Wednesday's trading session. Stocks across sectors are trading lower after CPI data showed worse-than-expected June inflation.
Cryptocurrency Chainlink Decreases More Than 4% Within 24 hours
Over the past 24 hours, Chainlink's (CRYPTO: LINK) price has fallen 4.37% to $5.88. This continues its negative trend over the past week where it has experienced a 7.0% loss, moving from $6.26 to its current price.
Cryptocurrency NEAR Protocol Decreases More Than 5% Within 24 hours
NEAR Protocol's (CRYPTO: NEAR) price has decreased 5.39% over the past 24 hours to $3.12, continuing its downward trend over the past week of -10.0%, moving from $3.46 to its current price.
Why Apple Shares Are Falling Today
Apple Inc (NASDAQ: AAPL) shares are trading lower by 1.12% to $144.22 Wednesday morning. Stocks across sectors are trading lower after CPI data showed worse-than-expected June inflation. A rise in inflation has caused concerns of a potential recession and more aggressive Federal Reserve policy.
NeuroSense Therapeutics Shares Move Sharply Higher; Traders Circulate Presentation Slide Saying PrimeC ‘Significantly Alters Key ALS Biomarkers’
https://docs.publicnow.com/viewDoc?hash_primary=E643C899EAD84D83637D61C470FEB3BAE9F37120
The Daily Biotech Pulse: AstraZeneca’s COVID-19 Vaccine As Effective As mRNA Shots, Humanigen’s Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth’s Alzheimer’s Program
Here's a roundup of top developments in the biotech space over the last 24 hours:
Humanigen’s Lenzilumab Disappoints In NIH-Backed COVID-19 Study
Humanigen Inc (NASDAQ: HGEN) has been informed of preliminary topline results from the ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospitalized COVID-19 patients.
